It seems that this company does not learn from it's mistakes. The previous time a similar failure occurred in their testing phase.
The more they prolong the testing, other companies will pass us by, and we will still be lingering and be left behind. Just so bad.
- Forums
- ASX - By Stock
- PAB
- Ann: Updated guidance for PAT-DX1 phase 1 clinical study
Ann: Updated guidance for PAT-DX1 phase 1 clinical study, page-46
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
-0.001(7.14%) |
Mkt cap ! $13.37M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $505 | 80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 5901591 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1528945 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 5901591 | 0.006 |
17 | 7830976 | 0.005 |
7 | 4425000 | 0.004 |
6 | 2930016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1528945 | 4 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
Last trade - 15.44pm 16/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |